Status:
RECRUITING
Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
18+ years
Brief Summary
Some hemostasis techniques require spectrophotometric measurements. These are then subject to interference from the sample's lipemia (postprandial, hypertriglyceridemia, etc.), which risks distorting ...
Eligibility Criteria
Inclusion
- Adult patient (≥ 18 years)
- Patient anticoagulated with an anti-Xa (UFH, LMWH, fondaparinux, danaparoid, apixaban, rivaroxaban)
- Sample sent to the HUS Hematology Laboratory and analyzed for measurement of the anti-Xa activity of an anticoagulant as part of routine care
Exclusion
- Patient with a basal lipidemic sample
- Sample of insufficient volume
Key Trial Info
Start Date :
March 11 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 11 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07200674
Start Date
March 11 2024
End Date
December 11 2025
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire d'Hématologie - Unité d'Hémostase - CHU de Strasbourg - France
Strasbourg, France, 67091